Cervarix

Recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from Trichoplusia ni cell)

Approval Information

Brand NameCervarix

Generic NameRecombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from Trichoplusia ni cell)

ApprovedOctober 2009

TypeInitial Approval

Review Reports

English Review Report

PDF · 1.07 MB

Japanese Review Report

PDF · 823.83 KB

Want structured data, translation summaries & alerts?

PharmaLens is building the most comprehensive English-language PMDA intelligence platform. Join the waitlist for early access.

Join the Waitlist

Source: PMDA Website. Review reports are provided under Japan's Public Data License v1.0. Translations and structured data by PharmaLens are unofficial and for reference only.

← Back to Drug Database